Cytogenetic studies in prostate cancer: Are we making progress?

Cancer Genetics and Cytogenetics

Volumn 95, Issue 1, 1997, Pages 116-121

  Brothman, Arthur R ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME 1; CHROMOSOME 17; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME DELETION; CYTOGENETICS; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

EID: 0030991656     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00302-0     Document Type: Article

References (53)

1. Parker SL, Tong T, Bolden S, Wingo PA (1996): Cancer Statistics, in CA-A. Cancer Journal for Clinicians, Vol 46:5-28.
2. Sandberg AA (1992): Chromosomal abnormalities and related events in prostate cancer. Hum Pathol 23 4:368-380.
3. Debruyne FM, Collins VP, VanDekken H, Jenkins RB, Klocker H, Schalken JA (1994): Cytogenetics of prostate cancer. Consensus on diagnosis and prognostic parameters in localized prostate cancer. Scand J Urol-Nephrol-Suppl. 162: 65-71.
4. Brothman AR (1996): Prostate Cancer: Molecular and Cellular Abnormalities. In: Molecular Biology of Cancer, ed. J.R. Bertino, Vol II, Academic Press, New York, pp. 1303-1313.
5. Brothman AR and Williams BJ (1997): Prostate cancer. In: Cytogenetic markers of human cancer. Eds. S. Wolman and S. Sell. Humana Press, Inc. Totowa. NJ (in press).
6. Konig JJ, Teubel W, van Dongen JW, Hagemejer A, Romign RC, Schroder RH (1993): Tissue culture loss of aneuploid cells from carcinomas of the prostate. Genes Chromosom Cancer 8:22-27.
7. Jones E, Zhu XL, Rohr LR, Stephenson RA, Brothman AR (1994): Aneusomy of chromosomes 7 and 17 detected by FISH in prostate cancer and the effects of selection in vitro. Genes Chrom Cancer 11:163-170.
8. Peehl DM, Stamey TA (1986): Serum-free growth of adult human prostatic epithelial cells. In Vitro Cell Dev Biol 22:82-90.
9. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C, Palotie A, Isola J, Kallioniemi O-P (1995): In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nature Gen 9:401-406.
10. Atkin NB and Baker MC (1985): Chromosome study of five cancers of the prostate. Hum Genet 70:359-364.
11. Lundgren R, Kristoffersson U, Heim S, Mandahl N, Mitelman F (1988): Multiple structural chromosome rearrangements, including del(7q) and del(10q), in an adenocarcinoma of the prostate. Cancer Genet Cytogenet 35:103-108.
12. Brothman AR, Peehl DM, Patel AM, McNeal JE (1990): Frequency and pattern of karyotypic abnormalities in human prostate cancer. Cancer Res 50:3795-3803.
13. Jackson-Cook C, Bae V, Edelman W, Brothman A, Ware J (1996): Cytogenetic characterization of the human prostate cancer cell line P69SV40T and its novel tumorigenic sublines M2182 and M15. Cancer Genet Cytogenet 87:14-23.
14. Babu VR, Miles BJ, Cerny JC, Weiss L, Van Dyke DL (1990): Cytogenetic study of four cancers of the prostate, Cancer Genet Cytogonot 48:83-87.
15. Brothman AR, Patel AM, Peehl DM, Schellhammer PF (1992): Analysis of prostatic tumor cultures using fluorescence in-situ hybridization (FISH). Cancer Genet Cytogenet 62:180-185.
16. Macoska JA, Micale MA, Sakr WA, Benson PD, Wolman SR (1993): Extensive genetic alterations in prostate cancer revealed by dual PCR and FISH analysis. Genes Chromosom Cancer 8:88-97.
17. Arps S, Rodewald A, Schmalenberger B, Carl P, Bressel M, Kastendieck H (1993): Cytogenetic survey of 32 cancers of the prostate. Cancer Genet Cytogenet 66:93-99.
18. Takahashi S, Qian J, Brown JA, Alcaraz A, Bostwick DG, Lieber MM, Jenkins RB (1994): Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization. Cancer Res 54:3574-3579.
19. Zitzelberger H, Szucs S, Weier H-U, Hehmann L, Braselmann H, Enders S, Schilling A, Bruel J, Hofler H, Bauchinger M (1994): Numerical abnormalities of chromosome 7 in human prostate cancer detected by fluorescence in situ hybridization (FISH) on paraffin-embedded tissue with centromere-specific DNA probes. J Pathol 172:325-335.
20. Visakorpi T, Hyytinen E, Kallioniemi A, Isola J, Kallioniemi O-P (1994): Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization. Am J Pathol 145(3):624-630.
21. Henke R-P, Kruger E, Ayhan N, Hubner D, Hammerer P (1994): Frequency and distribution of numerical chromosomal aberrations in prostate cancer. Hum Pathol 25:476-484.
22. Brown JA, Alcaraz A, Takahashi S, Persons DL, Lieber MM, Jenkins RB (1994): Chromosomal aneusomies detected by fluorescent in situ hybridization analysis in clinically localized prostate carcinoma. J Urol 152:1157-1162.
23. Bandyk MG, Zhao L, Troncoso P, Pisters LL, Palmer JL, von Eschenback AC, Chung LWK, Liang JC (1994): Trisomy 7: A potential cytogenetic marker of human prostate cancer progression. Genes Chromosom Cancer 9:19-27.
24. Alers JC, Krijtenburg PJ, Vissers KJ, Bosman FT, van der Kwast TH, van Dekken H (1995): Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: Analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias. Genes Chromosom Cancer 12:241-250.
25. Micale MA, Sanford JS, Powell IJ, Sakr WA, Wolman SR 1993): Defining the extent and nature of cytogenetic events in prostatic adenocarcinoma: paraffin FISH versus metaphase analysis. Cancer Genet Cytogenet 69:7-12.
26. Persons DL, Gibney DJ, Katzmann JA, Lieber MM, Farrow GM, Jenkins RB (1993): Use of fluorescent in situ hybridization for deoxyribonucleic acid ploidy analysis of prostatic adenocarcinoma. J Urol 150:120-125.
27. Baretton GB, Valina C, Vogt T, Schneiderbanger K, Diebold J, Lohrs U (1994): Interphase cytogenetic analysis of prostatic carcinomas by use of non-isotopic in situ hybridization. Cancer Res 54:4472-4480.
28. Bergerheim USR, Kunimi K, Collins VP, Ekman P (1991): Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma. Genes Chrom Cancer 3:215-220.
29. Macoska JA, Trybus TM, Sakr WA, Wolf MC, Benson PD, Powell IJ, Pontes JE (1994): Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res 54:3824-3830.
30. Matsuyama H, Pan Y, Skoog L, Tribukait B, Naito K, Ekman P, Lichter P, Bergerheim USR (1994): Deletion mapping of 8p in prostate cancer by fluorescence in situ hybridization. Oncogene 9:3071-3076.
31. Cher ML, MacGrogan D, Bookstein R, Brown JA, Jenkins RB, Jensen RH (1994): Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosom Cancer 11:153-162.
32. Visakorpi T, Kallioniemi AH, Syvanen A-C, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi O-P (1995): Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 55:342-347.
33. Williams BJ, Jones E, Kozlowski JM, Vessella R, Brothman AR (1997): Comparative genomic hybridization and molecular cytogenetic characterization of two prostate cancer xenografts. Genes Chromosom Cancer (in press).
34. Kallioniemi A, Kallioniemi O-P, Piper J, Tanner M, Stokkes T, Chen L, Smith HS, Pinkel D, Gray JW, Waldman FM (1994): Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization, Proc Natl Acad Sci USA 94:2156-2160.
35. Brothman AR, Lesho LJ, Somers KD, Schellhammer PF, Ladaga LE, Merchant DJ (1989): Cytogenetic analysis of four primary prostate cultures. Cancer Genet Cytogenet 37:241-248.
36. Lundgren R, Mandahl N, Heim S, Limon J, Henrikson H, Mitelman F (1992): Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chromosom Cancer 4:16-24.
37. Eagle LR, Yin X, Brothman AR, Williams BJ, Atkin NB, Prochownik EV (1995): Mutation of the MXI1 gene in prostate cancer. Nature Genet 9:249-255.
38. Oshimura M and Sandberg AA (1975): Isochromosome 17 in prostatic cancer. J Urol 114:249-250.
39. Brothman AR, Watson MJ, Zhu XL, Williams BJ, Rohr LR (1994): Evaluation of 20 archival prostate tumor specimens by fluorescence in situ hybridization (FISH). Cancer Genet Cytogenet 75:40-47.
40. Williams BJ, Jones E, Brothman AR (1995): Homologous centromere association of chromosomes 9 and 17 in prostate cancer. Cancer Genet Cytogenet 85:143-152.
41. Arason A, Barkadottir TB, Egilsson V (1993): Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostatic cancer. Am J Hum Genet 52:711-716.
42. Brothman AR, Steele MR, Williams BJ, Jones E, Odelberg S, Albertsen HM, Jorde LB, Rohr LR, Stephenson RA (1995): Loss of chromosome 17 loci in prostate cancer detected by polymerase chain reaction quantitation of allelic markers. Genes Chromosom Cancer 13:278-284.
43. Gao X, Zacharek A, Salkowski A, Grignon DJ, Sakr W, Porter AT, Honn KV (1995): Loss of heterozygosity of the BRCA1 and other loci on chromosome 17 in human prostate cancer. Cancer Res 55:1002-1005.
44. Williams BJ, Jones E, Zhu XL, Steele MR, Stephenson RA, Rohr LR, Brothman AR (1996): Evidence for a tumor suppressor gene distal to BRCA1 in prostate cancer. J Urol 155:720-725.
45. Rinker-Schaeffer CW, Hawkins AL, Ru N, Dong J, Stoica G, Griffin CA, Ichikawa T, Barrett JC, Isaacs JT (1994): Differential suppression of mammary and prostatic cancer metastasis by human chromosomes 17 and 11. Cancer Res 54:6249-6256.
46. Murakami Y, Brothman AR, Leach RJ, White RL (1995): Suppression of malignant phenotype in a human prostate cancer cell line by fragments of normal chromosomal region 17q. Cancer Res 55:3389-3394.
47. Joos S, Bergerheim USR, Pan Y, Matsuyama H, Bentz M, duManoir S, Lichter P (1995): Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization. Genes Chromosom Cancer 14:267-276.
48. Cher ML, Bova GS, Moore DH, Small EJ, Caroll PR, Pin SS, Epstein JI, Isaacs WB. Jensen RH (1996): Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 56:3091-3102.
49. Brothman AR, Peehl DM, Patel AM, MacDonald GR, McNeal JE, Ladaga LE, Schellhammer PF (1991): Cytogenetic evaluation of 20 cultured primary prostatic tumors. Cancer Genet Cytogenet 55:79-84.
50. Breitkreuz T, Konstantinos R, Lutz S, Seitz G, Bonkhoff H, Unteregger G, Zwergel T, Zang D, Wullich B (1993): Genotypic characterization of prostatic carcinomas: A combined cytogenetic, flow cytometry, and in situ DNA hybridization study. Cancer Res 53:4035-4040.
51. Limon J. Kristoffersson U, Heim S. Mandahl N, Mitelman F (1988): Multiple structural chromosome rearrangements, including del(7q) and del(10q), in an adenocarcinoma of the prostate. Cancer Genet Cytogenet 35:103-108.
52. Konig JJ, Teubel W, van Dongen JW, Romijn JC, Hagemeijer A, Schroder FH (1994): Loss and gain of chromosomes 1, 18 and Y in prostate cancer. Prostate 25:281-291.
53. Cher ML, Ito T, Weidner N, Carroll PR, Jensen RH (1995): Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH). J Urol 153:249-254.